Evidence map›Paper›PMID 35268795›Full record

ArticleMolecules (Basel, Switzerland)2022

Improved Wound Healing by Naringin Associated with MMP and the VEGF Pathway.

Jia-Hau Yen, Wan-Ting Chio, Chia-Ju Chuang, Hsin-Ling Yang, Sheng-Teng Huang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Food science & nutrition · 2026
    Article
  4. Article
  5. Evaluation of liposomeFrontiers in medical technology · 2026
    Article
  6. Erbin Inhibited AngiogenesisCurrent medicinal chemistry · 2026
    Article
  7. Article
  8. Polyphenols in wound healing: unlocking prospects with clinical applications.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jia-Hau YenCancer Research Center for Traditional Chinese Medicine, Department of Medical Research, China Medical University Hospital, Taichung 40402, Taiwan.
Wan-Ting ChioCancer Research Center for Traditional Chinese Medicine, Department of Medical Research, China Medical University Hospital, Taichung 40402, Taiwan.
Chia-Ju ChuangCancer Research Center for Traditional Chinese Medicine, Department of Medical Research, China Medical University Hospital, Taichung 40402, Taiwan.
Hsin-Ling YangInstitute of Nutrition, College of Biopharmaceutical and Food Sciences, China Medical University, Taichung 40402, Taiwan.ORCID 0000-0002-3561-7372
Sheng-Teng HuangCancer Research Center for Traditional Chinese Medicine, Department of Medical Research, China Medical University Hospital, Taichung 40402, Taiwan.ORCID 0000-0002-7495-6115
China Medical University · TW

Funding

An-Nan Hospital, China Medical University [ANHRF-110-25]China Medical University Hospital [DMR-110-189, DMR-111-005, DMR-111-013, DMR-111-016, and DMR-HHC-109-3]Ministry of Science and Technology of Taiwan [MOST 110-2320-B-039-40-]
6 · The paper itself

Abstract

This study aims to investigate the wound-healing effectiveness of the phenolic compound, naringin, both in vitro and in vivo. Male mice were shaved on their dorsal skin under isoflurane, a biopsy punch was made in four symmetrical circular resection windows (6 mm) to induce a wound. These excision wounds were used to study the topical effects of naringin in terms of various biochemical, molecular, and histological parameters. We observed a significant recovery in the wound area. Increased levels of MMP-2, 9, 14, TIMP-2, VEGF-A, and VEGF-R1 were induced by naringin in the HaCaT cells. The time course experiments further revealed that levels of VEGF-A and B increased within 36 h; whereas levels of VEGF-C decreased. In line with this, VEGF-R3 levels, but not VEGF-R1 and 2 levels, increased soon after stimulation; although the increase subsided after 36 h. Additionally, naringin cream upregulated wound healing in vitro. The blockage of VEGF by Bevacizumab abolished the function of naringin cream on cell migration. Histological alterations in the wounded skin were restored by naringin cream, which accelerated wound healing via upregulated expression of growth factors (VEGF-A, B, and C and VEGF-R3), and thus increased MMP-2, 9, 14 expressions.

Indexed as

FlavanonesVascular Endothelial Growth Factor AWound HealingAnimalsCell LineCell MovementHaCaT CellsHumansMaleMatrix Metalloproteinase 2Matrix MetalloproteinasesMiceSignal TransductionSkinFlavanonesMatrix Metalloproteinase 2Matrix MetalloproteinasesnaringinVascular Endothelial Growth Factor AMMPsnaringinVEGFRsVEGFswound healing

Identifiers

PMID35268795
PMCPMC8911856
OpenAlexW4220732038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.